IRIS
ROSSI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.294
AS - Asia 2.974
EU - Europa 2.887
SA - Sud America 397
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 10.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.206
CN - Cina 1.674
IE - Irlanda 701
SG - Singapore 623
RU - Federazione Russa 392
DE - Germania 372
FI - Finlandia 353
BR - Brasile 331
HK - Hong Kong 329
UA - Ucraina 328
IT - Italia 251
VN - Vietnam 156
GB - Regno Unito 150
SE - Svezia 127
FR - Francia 56
BE - Belgio 53
CA - Canada 47
IN - India 39
MX - Messico 30
JP - Giappone 27
BD - Bangladesh 25
AR - Argentina 24
PL - Polonia 23
TR - Turchia 19
AT - Austria 14
NL - Olanda 13
CZ - Repubblica Ceca 12
ES - Italia 11
ID - Indonesia 11
CO - Colombia 10
EC - Ecuador 10
IR - Iran 10
MA - Marocco 10
ZA - Sudafrica 10
PK - Pakistan 8
IQ - Iraq 7
AL - Albania 6
LT - Lituania 6
BO - Bolivia 5
CL - Cile 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
NP - Nepal 4
PY - Paraguay 4
BY - Bielorussia 3
EU - Europa 3
GR - Grecia 3
KR - Corea 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
PE - Perù 2
RO - Romania 2
SR - Suriname 2
TM - Turkmenistan 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
YE - Yemen 1
Totale 10.599
Salva come PNG Salva come JPEG
Città #
Dublin 700
Chandler 657
Dallas 555
Beijing 406
Jacksonville 383
Hong Kong 329
Singapore 325
Nanjing 323
Ashburn 293
Ann Arbor 235
Boardman 180
Munich 133
Los Angeles 128
Nanchang 127
Helsinki 120
Princeton 111
Lawrence 109
Shenyang 105
Wilmington 99
Changsha 97
Medford 95
Hebei 81
New York 75
Shanghai 73
Pavia 67
Moscow 63
Jiaxing 62
Woodbridge 62
Tianjin 60
Hangzhou 58
Turku 57
Ho Chi Minh City 54
Brussels 52
Milan 48
Buffalo 46
Redondo Beach 44
São Paulo 38
Hanoi 32
Verona 27
Houston 23
Washington 23
Tokyo 22
San Francisco 21
Chicago 19
Seattle 19
Warsaw 19
Dearborn 18
Falkenstein 17
Montreal 17
Brooklyn 16
Orem 16
Santa Clara 16
Auburn Hills 15
Toronto 15
Fairfield 14
Frankfurt am Main 14
Norwalk 14
Rio de Janeiro 14
The Dalles 14
London 13
Poplar 13
Stockholm 13
Atlanta 12
Kunming 12
Nuremberg 12
Ankara 11
Chennai 11
Denver 11
San Giuliano Milanese 11
Belo Horizonte 10
Guangzhou 10
Jinan 10
Boston 9
Vigevano 9
Des Moines 8
Ningbo 8
Rome 8
Brasília 7
Buenos Aires 7
Dhaka 7
Johannesburg 7
Vienna 7
Zhengzhou 7
Brno 6
Charlotte 6
Falls Church 6
Haiphong 6
Mexico City 6
Olomouc 6
Phoenix 6
Piscataway 6
Can Tho 5
Columbus 5
Da Nang 5
Manchester 5
Mumbai 5
Ninh Bình 5
Pescara 5
Quận Bảy 5
Secaucus 5
Totale 7.181
Salva come PNG Salva come JPEG
Nome #
Combined antiresorptive and new anabolic drug approach in osteogenesis imperfecta zebrafish models 163
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 156
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 151
Adesion proteins in CHO cells. 145
Cartilage histogenesis in a murine model of chondrodysplasia 138
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 137
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. 137
Improved prolidase activity assay allowed enzyme kinetic characterization and faster prolidase deficiency diagnosis 135
A Mn(II)-Mn(II) center in human prolidase 133
A novel splicing mutation causes an undescribed type of analbuminemia. 133
Stability and networks of hydrogen bonds of the collagen triple helical structure: influence of pH and chaotropic nature of three anions. 129
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 125
Partial rescue of biochemical parameters after hematopoietic stem cell transplantation in a patient with prolidase deficiency due to two novel PEPD mutations 121
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 121
Diastrophic Dysplasia Sulfate Transporter (SLC26A2) Is Expressed in the Adrenal Cortex and Regulates Aldosterone Secretion. 121
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 120
Matrix disruptions, growth, and degradation of cartilage with impaired sulfation. 118
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 117
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 116
Comparative analysis of the expression of methionine sulfoxide reductase enzymes in human blood cells 115
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion 114
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 113
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach 113
Methionine sulfoxide reductase enzymes (Msr): a comparative analysis of the levels of expression in human blood cells 112
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification 112
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 110
Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen 110
Alteration of proteoglycan sulfation affects bone growth and remodeling. 110
Neutrophil granulocytes uniquely express, among human blood cells, high levels of Methionine-sulfoxide-reductase enzymes. 109
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 108
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 108
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 107
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 106
Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate 106
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 104
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 104
Analbuminemia in a Swiss family is caused by a C --> T transition at nucleotide 4446 of the albumin gene. 104
Role of the advanced glycation end products receptor in Crohn’s disease inflammation 104
Fast screening of glycosaminoglycan disaccharides by fluorophore-assisted carbohydrate electrophoresis (FACE): applications to biologic samples and pharmaceutical formulations 103
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 101
Lack of prolidase causes a bone phenotype both in human and in mouse 101
Early Fracture Healing is Delayed in the Col1a2 +/G610C Osteogenesis Imperfecta Murine Model 101
Polyethylene Glycol-Poly-Lactide-co-Glycolide Block Copolymer-Based Nanoparticles as a Potential Tool for Off-Label Use of N-Acetylcysteine in the Treatment of Diastrophic Dysplasia 99
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 98
Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta 98
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 97
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 97
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 97
Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients. 96
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. 96
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 95
Novel nonsense mutation causes analbuminemia in a Moroccan family. 94
Effect of the triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in human skin fibroblast cultures. 94
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 94
Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype 94
A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations 93
Bone cell differentiation and mineralization in wild-type and osteogenesis imperfecta zebrafish are compromised by per- and poly-fluoroalkyl substances (PFAS) 92
A novel mutation in the sulphate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. 92
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 92
Self-aggregation of fibrillar collagens I and II involves lysine side chains. 92
Ultrastructural aspects of cartilage histogenesis in a model of chondrodysplasia 92
Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica 91
Stability of type I collagen peptide trimers. 90
A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans. 89
Molecular diagnosis of analbuminemia: A novel mutation identified in two amerindian and two Turkish families 86
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. 86
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 85
A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. 85
Mucosal expression of the receptor for the advanced glycation end products (RAGE) in patients with inflammatory bowel disease (IBD) 84
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 84
Achondrogenesis type 1B is caused by mutations in the diastrophic dysplasia sulfate transporter gene 83
Bone and connective tissue disorders caused by defects in glycosaminoglycan biosynthesis: a panoramic view 82
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and collagen expression in the exostoses. 81
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis. 79
Type I collagen CNBr peptides: species and behavior in solution 78
Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity 78
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 76
Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes 76
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 75
The receptor for the advanced glycation end products is overexpressed in the intestinal mucosa of patients with crohn’s disease 74
Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta. 74
Analysis of proteoglycan synthesis and secretion in cell culture systems 73
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 73
Skeletal Dysplasias Caused by Sulfation Defects 71
Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for a Leu483Pro substitution in the diastrophic dysplasia sulfate transporter 70
Knocking out TMEM38B in human foetal osteoblasts hFOB 1.19 by CRISPR/Cas9: A model for recessive OI type XIV 69
Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta 68
The administration of exogenous HSP47 as a collagen-specific therapeutic approach 67
Diastrophic dysplasia sulfate transporter (DTDST) gene is not involved in pseudodiastrophic dysplasia 66
Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. 66
FACE analysis as a fast and reliable methodology to monitor the sulfation and total amount of chondroitin sulfate in biological samples of clinical importance. 66
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 66
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes and diagnostic relevance. 65
New dysplasia or achondrogenesis type 1 B? The importance of histology and molecular biology in delineating skeletal dysplasias. 65
Phenotypic characterization of immortalized chondrocytes from a desbuquois dysplasia type 1 mouse model: A tool for studying defects in glycosaminoglycan biosynthesis 65
Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. 63
FGF signalling regulates bone growth through autophagy 63
Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: congenital dislocations and vertebral changes as principal diagnostic features 63
Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing 63
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias 62
Totale 9.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.740
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021411 0 0 0 0 0 75 13 102 29 91 82 19
2021/2022528 12 10 14 13 13 9 13 40 21 18 87 278
2022/20231.871 180 175 15 151 194 165 6 88 804 20 46 27
2023/2024664 90 141 25 48 63 155 15 40 9 24 28 26
2024/20252.095 54 133 61 61 84 92 88 99 542 62 297 522
2025/20262.550 363 536 560 492 529 70 0 0 0 0 0 0
Totale 10.808